TY - JOUR
T1 - CLINICAL USEFULNESS OF MONOCLONAL- ANTIBODY PHENOTYPING IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA
AU - Kersey, John
AU - Abramson, Candice
AU - Perry, Guy
AU - Goldman, Anne
AU - Nesbit, Mark
AU - Gajl-Peczalska, Kazimiera
AU - Lebien, Tucker
N1 - Funding Information:
This work was supported in part by grants from the National Cancer
PY - 1982/12/25
Y1 - 1982/12/25
N2 - Lymphoblasts from 59 children with non-T, non-B acute lymphoblastic leukaemia were studied with monoclonal antibodies to four cell-surface proteins. 87% of the children had lymphoblasts positive for HLA-DR, 82% for p30, 75% for p24, and 72% for CALLA. The commonest composite phenotype was HLA-DR+ p30+ CALLA+ p24+. Significant correlations were seen between expression of HLA-DR, p30, and CALLA, but not p24. p30- and CALLA- phenotypes were found in patients with high white-blood-cell counts (WBC) and splenomegaly. With standard chemotherapy, disease-free survival from time of remission was shorter in p30- and CALLA- patients than in others. Splenomegaly was associated with poor disease-free survival and provided prognostic information independent of phenotype. High WBC was less significant than phenotype in predicting outcome and was not independent of phenotype.
AB - Lymphoblasts from 59 children with non-T, non-B acute lymphoblastic leukaemia were studied with monoclonal antibodies to four cell-surface proteins. 87% of the children had lymphoblasts positive for HLA-DR, 82% for p30, 75% for p24, and 72% for CALLA. The commonest composite phenotype was HLA-DR+ p30+ CALLA+ p24+. Significant correlations were seen between expression of HLA-DR, p30, and CALLA, but not p24. p30- and CALLA- phenotypes were found in patients with high white-blood-cell counts (WBC) and splenomegaly. With standard chemotherapy, disease-free survival from time of remission was shorter in p30- and CALLA- patients than in others. Splenomegaly was associated with poor disease-free survival and provided prognostic information independent of phenotype. High WBC was less significant than phenotype in predicting outcome and was not independent of phenotype.
UR - http://www.scopus.com/inward/record.url?scp=0020368680&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020368680&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(82)91326-5
DO - 10.1016/S0140-6736(82)91326-5
M3 - Article
C2 - 6129506
AN - SCOPUS:0020368680
SN - 0140-6736
VL - 320
SP - 1419
EP - 1423
JO - The Lancet
JF - The Lancet
IS - 8313
ER -
